Jefferson CFO Walks Back Stance At Einstein Antitrust Trial
Law360 (September 14, 2020, 11:10 PM EDT) -- Thomas Jefferson Health's finance chief conceded Monday during arguments over the Federal Trade Commission's bid to block a merger with Albert Einstein Healthcare that Jefferson had no evidence its partner was in danger of bankruptcy, despite painting Einstein's finances as "bleak" in earlier defenses of the deal.
The proposed merger with Albert Einstein could give the combined Philadelphia-area venture more clout with insurers, Jefferson CFO Peter L. DeAngelis Jr. said during the first day of arguments in the Pennsylvania federal trial over the FTC's bid for a preliminary injunction to block the deal pending an antitrust ruling by the agency.
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!